Role of homoeopathic medicines in management of polycystic ovarian syndrome

Utility of constitutional homoeopathic medicines in cases of polycystic ovarian syndrome a clinical trial. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102989

Enrollment

Registered

2026-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: homoeopathic management: Individualized homoeopathic medicine using constitutional approach and 30 no globules per dose potency as per individual case frequency depending upon susceptib

Eligibility

Inclusion criteria

Inclusion criteria: All the patients fulfilling case definition of PCOS. Patients with age 15-35 years.

Exclusion criteria

Exclusion criteria: Patients not fulfilling case definition of PCOS. Patients ongoing allopathic treatment of PCOS. All immunosuppressant patients.

Design outcomes

Primary

Measure	Time frame
Outcome will be measured by improvement in quality of life.Timepoint: Outcome assessment will be done by applying criteria baseline 0 midstudy 4 weeks 2nd followup poststudy 8 weeks 4th followup	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Srushti Sunil Ogale

Dr J J Magdum homoeopathic medical college jaysingpur

dr.rafat.jinabade@gmail.com9881447608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026